Objective: The objective of this study was to evaluate the accuracy of a beta prototype version of a new portable blood glucose meter in feline patients.
Animals: 60 client-owned cats.
Methods: In this prospective study, 3-mL blood samples were collected from each cat and analyzed in triplicate using a beta prototype device (AlphaTRAK 3 [AT3]) and by a reference lab standard immediately after collection. Accuracy of the AT3 device was determined in accordance with the International Organization of Standardization (ISO) 15197:2013 criteria, including Bland-Altman plotting and consensus error grid analysis. A Passing-Bablok regression analysis was also performed.
Results: 96% of feline measurements fell within the ISO accuracy threshold, and 100% of measurements fell within zones A and B of the consensus error grid, meeting the ISO accuracy requirements. There was no significant bias in the data according to the Bland-Altman analysis. Within the full range of glucose concentrations (20 to 750 mg/dL) the correlation coefficient between the AT3 and the reference lab standard was 0.99. There was no significant constant or proportional bias present in the data.
Clinical Relevance: The AT3 device met the ISO requirements and is accurate for measurement of blood glucose concentrations in cats.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2460/javma.23.08.0457 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!